News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website


GT Medical Technologies Announces Publication of Data Showing Company’s Targeted Therapy is Effective for Treating Recurrences of Common Type of Brain Tumor


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 This is a new type of radiation therapy which is implanted at the time of surgery. It is made up of biodegradable wafers. It has FDA clearance so it can be used now.  The current article talks about using it for recurrent meningiomas, but it can also be used for any primary or metastatic recurrent brain tumors.  Interesting concept. Check their website for more details.


Posted on: 01/31/2019

GT Medical Technologies Announces Publication of Data Showing Company’s Targeted Therapy is Effective for Treating Recurrences of Common Type of Brain Tumor

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740